drugset
Drugs / umbilical cord blood derived mononuclear cells
last change Apr 2021 re-read 3 minutes ago

umbilical cord blood derived mononuclear cells

Cell therapy

Developed for
hypoplastic left heart syndrome
Investigated by
Children's Hospital Colorado · Children's Hospital Los Angeles · Children's Hospital of Philadelphia · Children's Hospitals and Clinics of Minnesota · Mayo Clinic · Timothy J Nelson, MD, PhD
+1 more · University of Oklahoma

Trials 1

today NCT01883076 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01883076 May 2013 → Apr 2021 hypoplastic left heart syndrome Timothy J Nelson, MD, PhD Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as umbilical cord blood derived mononuclear cells “umbilical cord blood derived mononuclear cells” NCT01883076 ↗
Modality Cell therapy “cell-based regenerative therapy” NCT01883076 ↗
Route Other “intramyocardial delivery” NCT01883076 ↗